BioTech Innovation and National Security Continuation Act

HR 9900 extends the operational timeline of the National Security Commission on Emerging Biotechnology. It modifies provisions in the 2022 National Defense Act by making expired appointments valid, changing the reporting deadline from 3 years to 3.5 years after commission formation, and setting a new final report deadline of December 31, 2026. The bill directly affects the Commission's membership structure and reporting requirements without altering its core mission. This is a procedural adjustment to maintain the Commission's continuity, not a substantive policy change.